BIOMAT Database Logo BIOMAT Database Logo

Rapidly developed BRAF inhibitor-induced verrucous keratosis. 2017

Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Department of Dermatological Oncology, National Cancer Center Hospital, Tokyo, Japan.

UI MeSH Term Description Entries
D007642 Keratosis Any horny growth such as a wart or callus. Keratoderma Blennorrhagicum,Keratoma,Keratosis Blennorrhagica,Blennorrhagica, Keratosis,Blennorrhagicas, Keratosis,Blennorrhagicum, Keratoderma,Blennorrhagicums, Keratoderma,Keratoderma Blennorrhagicums,Keratomas,Keratoses,Keratosis Blennorrhagicas
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D048493 Proto-Oncogene Proteins B-raf A raf kinase subclass found at high levels in neuronal tissue. The B-raf Kinases are MAP kinase kinase kinases that have specificity for MAP KINASE KINASE 1 and MAP KINASE KINASE 2. B-raf Kinase,BRAF Kinase,B-raf Kinases,BRAF Kinases,Proto-Oncogene Protein B-raf,B raf Kinase,B raf Kinases,B-raf, Proto-Oncogene Protein,B-raf, Proto-Oncogene Proteins,Kinase, B-raf,Kinase, BRAF,Protein B-raf, Proto-Oncogene,Proteins B-raf, Proto-Oncogene,Proto Oncogene Protein B raf,Proto Oncogene Proteins B raf

Related Publications

Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
BRAF inhibitor induced verrucal keratosis.
February 2014, The American Journal of dermatopathology,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Testing for human papillomavirus in BRAF inhibitor-associated verrucous keratoses.
January 2015, Journal of cutaneous pathology,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Rapidly Changing Serous Detachment During BRAF and MEK Inhibitor Therapy.
December 2021, Cureus,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Extensive verrucous seborrheic keratosis mimicking deep mycoses.
July 2011, Indian dermatology online journal,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Keratosis lichenoides chronica mimicking verrucous secondary syphilis.
September 2003, Journal of the American Academy of Dermatology,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Verrucous melanoma masquerading as a seborrheic keratosis.
February 2019, Dermatology online journal,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Giant irritated seborrheic keratosis mimicking verrucous carcinoma.
August 1985, The Journal of dermatology,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Treatment of BRAF inhibitor-induced hyperkeratosis.
May 2013, Acta oncologica (Stockholm, Sweden),
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
Spindle cell squamous cell carcinoma arising from verrucous hyperplasia during BRAF inhibitor therapy for melanoma.
April 2015, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Yoshio Nakamura, and Taisuke Mori, and Yujiro Takae, and Arata Tsutsumida, and Akira Takahashi, and Kenjiro Namikawa, and Ikuko Hirai, and Naoya Yamazaki
[BRAF Inhibitor-Induced Erythema Nodosum-Like Lesions].
May 2016, Gan to kagaku ryoho. Cancer & chemotherapy,
Copied contents to your clipboard!